JSW
OGN icon

Journey Strategic Wealth’s Organon & Co OGN Stock Holding History

Journey Strategic Wealth’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,081
Closed -$108K – 868
2025
Q4 		$108K Buy
+15,081
New +$119K ﹤0.01% 747
2025
Q2 		– Sell
-10,177
Closed -$152K – 689
2025
Q1 		$152K Sell
10,177
-1,839
-15% -$28.3K 0.01% 478
2024
Q4 		$179K Sell
12,016
-768
-6% -$12.5K 0.01% 473
2024
Q3 		$245K Sell
12,784
-34
-0.3% -$705 0.01% 394
2024
Q2 		$265K Sell
12,818
-152
-1% -$3.02K 0.01% 282
2024
Q1 		$244K Sell
12,970
-259
-2% -$4.45K 0.01% 231
2023
Q4 		$191K Buy
+13,229
New +$180K 0.01% 208

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Journey Strategic Wealth's OGN Position: Q1 2026 in Review

Journey Strategic Wealth sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 15,081 shares — an estimated $108K sold.

Journey Strategic Wealth first reported a position in OGN in Q4 2023 and held it in 7 quarters. The position peaked at $265K in Q2 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Journey Strategic Wealth reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Journey Strategic Wealth sold 15,081 Organon & Co shares in Q1 2026, an estimated $108K.
  • Journey Strategic Wealth first reported a position in Organon & Co in Q4 2023 and held it in 7 quarters.
  • Journey Strategic Wealth's Organon & Co position peaked at $265K in Q2 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.